Skip to content

GlideScope Videolaryngoscopy in Patients With Reduced Mouth Opening

GlideScope Videolaryngoscopy in Patients With Reduced Mouth Opening, a Prospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04174833
Enrollment
30
Registered
2019-11-22
Start date
2021-01-20
Completion date
2021-11-17
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intubation;Difficult, Small Mouth, Videolaryngoscopy

Keywords

GlideScope, Airway Management, Videolaryngoscopic Intubation

Brief summary

This study aims to evaluate the clinical performance, quality of larynx visualization and difficulty of videolaryngoscopic intubation in patients with a reduced mouth opening (1.0 to 3.0 cm) utilizing the latest generation of GlideScopeTM Spectrum low profile laryngoscopy system.

Detailed description

Reduced mouth opening in adults has been proven an important risk factor for difficult endotracheal intubation utilizing both direct and indirect laryngoscopy techniques, and a major reason for anesthesia-related adverse events. Over the past two decades, videolaryngoscopy has evolved to be the primary indirect laryngoscopy technique in a difficult endotracheal intubation setting. The possibility for optimal visualization of the laryngeal structures renders this method particularly helpful in patients with limited mouth opening. Especially videolaryngoscopy with acute-angle blades has been proposed to be favorable over conventional direct laryngoscopy in this setting. However, previous research has shown that a mouth opening of approximately 2.0 - 3.0 cm represents an independent risk factor and a possible critical lower limit for safe videolaryngoscopic intubation. The latest generation of GlideScopeTM Spectrum blades may provide sufficient intubation conditions even in patients with a maximum mouth opening below 3.0 cm. Our research group aims to evaluate the clinical performance, quality of larynx visualization and severity of videolaryngoscopic intubation the GlideScopeTM Spectrum system in patients with a small mouth opening.

Interventions

None listed

Sponsors

Verathon
CollaboratorINDUSTRY
Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for non-cardiac surgery * Required general anesthesia and endotracheal intubation * Mouth opening between 1.0 and 3.0 cm (any reason) recognized during preoperative assessment * Written consent provided

Exclusion criteria

* Pregnant or breastfeeding women * Confirmed indication for awake fiberoptic intubation, especially due to enoral and pharyngeal tumors, abscesses or other obstructive lesions * Endotracheal intubation planned without deep general anesthesia or without neuromuscular blockade (e.g. awake videolaryngoscopy) * Qualification for rapid sequence anesthesia induction due to risk of pulmonary aspiration * Loose teeth

Design outcomes

Primary

MeasureTime frameDescription
Successful videolaryngoscopic endotracheal intubation rateWithin 1 hour after anesthesia inductionObservation during airway management

Secondary

MeasureTime frameDescription
First pass success rateWithin 1 hour after anesthesia inductionObservation during airway management
Endotracheal intubation difficultyWithin 1 hour after concluded endotracheal intubationSubjective rating on a numeric rating scale \[0-100\]; 0 - very easy; 100 - very difficult
Best view obtainedWithin 1 hour after concluded endotracheal intubationCormack-Lehane classification
Intubation timeWithin 1 hour after anesthesia inductionObservation during airway management
Number of attemptsWithin 1 hour after anesthesia inductionObservation during airway management

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026